In this video interview, David Morton, PhD, director of biostatistics at Certara, outlines how increasing FDA support is helping drive adoption of Bayesian methods, particularly in rare disease and ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Bayesian statistical models could help address recruitment challenges, but experts agree that sponsors must first understand – and be prepared - for the additional work required to implement them ...

A new study introduces a global probabilistic forecasting model that predicts when and where ionospheric disturbances—measured by the Rate of total electron content (TEC) Index (ROTI)—are likely to ...

Since the third Gaia data release in 2022, wide binary stars with separation greater than several thousand astronomical units have been intensely investigated across the world, to probe the nature of ...

The post How To Speed Up the Search for Cures Through a Change in Probability Theory appeared first on Reason.com.

WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...

We discuss Bayesian approaches for learning Bayesian networks from data. First, we review a metric for computing the relative posterior probability of a network structure given data developed by ...

This study proposes an important new approach to analyzing cell-count data, which are often undersampled and cannot be accurately assessed using traditional statistical methods. The case studies ...

Naive Bayes is a widely used classification algorithm known for its simplicity and efficiency. This package takes naive Bayes to a higher level by providing more flexible and weighted variants, making ...